End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | +0.53% | +2.46% | -42.73% |
Business Summary
Number of employees: 48
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Next-generation Cell and Gene Therapies
100.0
%
| 4 | 100.0 % | 3 | 100.0 % | -40.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 3 | 100.0 % | -40.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Lu
FOU | Founder | 43 | 16-06-08 |
Kanya Rajangam
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Berland
BRD | Director/Board Member | 69 | 21-05-31 |
Director/Board Member | 64 | 16-06-30 | |
Omid Farokhzad
BRD | Director/Board Member | 55 | 22-06-07 |
James Collins
BRD | Director/Board Member | 58 | 22-06-07 |
Thomas P. Chung
BRD | Director/Board Member | - | 22-08-31 |
Timothy Lu
FOU | Founder | 43 | 16-06-08 |
Director/Board Member | 59 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,755,021 | 35,505,472 ( 77.60 %) | 0 | 77.60 % |
Company contact information
Senti Biosciences, Inc.
2 Corporate Drive First Floor
94080, South San Francisco
+
http://www.sentibio.comSector
1st Jan change | Capi. | |
---|---|---|
-42.73% | 17.39M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- SNTI Stock
- Company Senti Biosciences, Inc.